SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001641489-23-000040
Filing Date
2023-06-21
Accepted
2023-06-21 16:27:02
Documents
1
Period of Report
2022-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1687379213.html 4/A  
1 FORM 4/A wk-form4a_1687379213.xml 4/A 3376
  Complete submission text file 0001641489-23-000040.txt   4871
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O VTV THERAPEUTICS INC. 3980 PREMIER DRIVE HIGH POINT NC 27265
Business Address
Isaacsohn Jonathan (Reporting) CIK: 0001943095 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37524 | Film No.: 231030226